Doxofylline Glucose Injection
Indication
This product is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc. It can also be used for acute heart failure and cardiac asthma.
Packaging Specification
100 ml: 0.3 g doxofylline and 5 g glucose
Manufacturer
Anhui Fengyuan Pharmaceutical Co., Ltd.
-
Founded in:
1997-08-30 -
Address:
No. 188 Tongjiang Avenue, Wuwei City, Wuhu City, Anhui Province -
Tax NO.:
91340200153701860P -
Registered Funds:
464.773722 million yuan -
Website:
-
Email: